Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Watel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Thrombosis Research|February 1, 1992
Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolismB Jude, N Amrouni, I Deguine, et al.
La Revue De Medecine Interne|September 1, 1986
[Inhibitors of factor VIII in non-hemophilic patients. Biological and therapeutic aspects. Apropos of 3 cases]B Jude, J Goudemand, J P Jouet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1986
[Surgery of acquired heart valve diseases in France: developments in a 10-year period. A multicentric study]G Hanania, B Champeau, P Collin, et al.
Annales De Chirurgie|January 1, 1989
[Durability of the Carpentier-Edwards porcine bioprosthesis in aortic or mitral positions. 10 years' results on 458 surgically treated cases]G Soots, C Stankowiak, H Warembourg, et al.
European Heart Journal|October 1, 1984
Experience with 813 aortic or mitral valve replacements with the Carpentier-Edwards bioprosthesis: Five year resultsG Soots, A Pieronne, J P Roux, et al.
Mayo Clinic Proceedings|March 13, 2003
Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart diseaseHélène G Bulckaen, François L Puisieux, Emmanuel D Bulckaen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Thrombosis Research|February 1, 1992
Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolismB Jude, N Amrouni, I Deguine, et al.
La Revue De Medecine Interne|September 1, 1986
[Inhibitors of factor VIII in non-hemophilic patients. Biological and therapeutic aspects. Apropos of 3 cases]B Jude, J Goudemand, J P Jouet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1986
[Surgery of acquired heart valve diseases in France: developments in a 10-year period. A multicentric study]G Hanania, B Champeau, P Collin, et al.
Annales De Chirurgie|January 1, 1989
[Durability of the Carpentier-Edwards porcine bioprosthesis in aortic or mitral positions. 10 years' results on 458 surgically treated cases]G Soots, C Stankowiak, H Warembourg, et al.
European Heart Journal|October 1, 1984
Experience with 813 aortic or mitral valve replacements with the Carpentier-Edwards bioprosthesis: Five year resultsG Soots, A Pieronne, J P Roux, et al.
Mayo Clinic Proceedings|March 13, 2003
Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart diseaseHélène G Bulckaen, François L Puisieux, Emmanuel D Bulckaen, et al.
Pageof 5